MAPT and Cognitive impairment: Therefore, there is important clinical significance to explore the changes of concentration of serum phosphorylated tau181 (P-tau181) and T-tau in PE patients, pregnant healthy controls (PHCs), and non-pregnant healthy controls (NPHCs), and their correlation with cognitive impairment.